Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Yuhki SAKURAOKA"'
Autor:
Takatsugu Matsumoto, Takayuki Shimizu, Shun Sato, Genki Tanaka, Takamune Yamaguchi, Kyung-Hwa Park, Yuhki Sakuraoka, Takayuki Shiraki, Shozo Mori, Yukihiro Iso, Takehiko Nemoto, Keiichi Kubota, Yumi Nozawa, Kazuyuki Ishida, Taku Aoki
Publikováno v:
Surgical Case Reports, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Background Microhepatocellular carcinoma with a gross bile duct tumor thrombus is extremely rare, making the correct preoperative diagnosis difficult. Case presentation A 78-year-old man was referred to our department for close examination o
Externí odkaz:
https://doaj.org/article/989043c0c86140b198044a8a44b77df1
Autor:
Yuhki Sakuraoka, Keiichi Kubota, Genki Tanaka, Takayuki Shimizu, Kazuma Tago, Kyung Hwa Park, Takatsugu Matsumoto, Takayuki Shiraki, Shozo Mori, Yukihiro Iso, Taku Aoki
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Background The tumor location is the most simple clinical factor and important in liver surgery to make surgical procedure. However, no previous study has investigated the prognostic differences and clinical features of hepatocellular carcin
Externí odkaz:
https://doaj.org/article/eeaf2385d4a94c79aa633c426fde0970
Autor:
Takayuki Shimizu, Mitsuru Ishizuka, Takayuki Shiraki, Yuhki Sakuraoka, Shozo Mori, Akihito Abe, Yukihiro Iso, Kazutoshi Takagi, Taku Aoki, Keiichi Kubota
Publikováno v:
Annals of Gastroenterological Surgery, Vol 4, Iss 5, Pp 580-590 (2020)
Abstract Aim The lymphocyte‐to‐monocyte ratio (LMR) is useful for predicting the prognosis of patients with gastric cancer (GC) and those with colorectal cancer (CRC) undergoing surgery. The relationship between the LMR and postoperative outcome
Externí odkaz:
https://doaj.org/article/f8d7a5246add4d999336534a4959067d
Autor:
Takayuki Shimizu, Mitsuru Ishizuka, Kyung Hwa Park, Takayuki Shiraki, Yuhki Sakuraoka, Shozo Mori, Yukihiro Iso, Masato Kato, Taku Aoki, Keiichi Kubota
Publikováno v:
Annals of Gastroenterological Surgery, Vol 3, Iss 3, Pp 325-335 (2019)
Abstract Background and Aim Although the Cancer of the Liver Italian Program (CLIP) score is useful for prognostication of patients with hepatocellular carcinoma (HCC), a previous study has reported that the CLIP score was unable to stratify the post
Externí odkaz:
https://doaj.org/article/5e813da19e2a45b0bdfd2a621e664986
Autor:
Takayuki Shimizu, Keiichi Kubota, Takashi Suzuki, Takatsugu Matsumoto, Takayuki Shiraki, Yuhki Sakuraoka, Shozo Mori, Yukihiro Iso, Masato Kato, Mitsuru Ishizuka, Taku Aoki
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-5 (2019)
Abstract Background Although an inferior vena cava (IVC) filter is used for preventing pulmonary thromboembolism (PTE) in patients with deep vein thrombosis, IVC filter penetration in the duodenum is a rare complication. Case presentation A 35-year-o
Externí odkaz:
https://doaj.org/article/39df50d47d6041f68c1420ab1b34226a
Autor:
SHOTARO MIYASHITA, TAKAYUKI SHIMIZU, MITSURU ISHIZUKA, MAIKO NIKI, YUSUKE NISHI, NORISUKE SHIBUYA, HIROYUKI HACHIYA, TAKATSUGU MATSUMOTO, YUHKI SAKURAOKA, TAKAYUKI SHIRAKI, SHOZO MORI, YUKIHIRO ISO, ATSUSHI IRISAWA, TAKU AOKI
Publikováno v:
Anticancer Research. 43:2219-2225
Autor:
Shotaro MIYASHITA, Takayuki SHIMIZU, Maiko NIKI, Kotaro SUDA, Kyung Hwa PARK, Takatsugu MATSUMOTO, Takayuki SHIRAKI, Yuhki SAKURAOKA, Shozo MORI, Yukihiro ISO, Mitsuru ISHIZUKA, Taku AOKI, Junji KITA, Keiichi KUBOTA
Publikováno v:
Suizo. 37:47-54
Autor:
Nana Yazawa, Takayuki Shimizu, Yuhki Sakuraoka, Yukihiro Iso, Taku Aoki, Mariko Kumazawa, Katsutoshi Ishihara, Yasukazu Shioyama, Atsushi Irisawa, Keiichi Kubota
Publikováno v:
Kanzo. 62:800-805
Autor:
Shozo Mori, Takayuki Shimizu, Mitsuru Ishizuka, Shun Sato, Yukihiro Iso, Takayuki Shiraki, Yuhki Sakuraoka, Takatsugu Matsumoto, Keiichi Kubota, Taku Aoki
Publikováno v:
Anticancer Research. 41:5171-5177
BACKGROUND/AIM Computed tomography and positron emission tomography cannot detect all minute distant metastases and fully evaluate extensive vascular invasion in patients with pancreatic ductal adenocarcinoma (PDAC). The aim of this study was to inve
Autor:
Yuhki Sakuraoka, Yukihiro Iso, Keiichi Kubota, Takamune Yamaguchi, Shozo Mori, Takayuki Shimizu, Kyung Hwa Park, Takatsugu Matsumoto, Taku Aoki, Takayuki Shiraki
Publikováno v:
Pancreas. 50:744-750
Although neoadjuvant chemotherapy (NAC)-gemcitabine plus S-1 (GS) has been reported to have a survival benefit in patients with resectable pancreatic ductal adenocarcinoma (PDAC), optimal candidates for NAC-GS have not been clearly identified.A total